Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Asset Utilization Ratio (2024 - 2025)

NewAmsterdam Pharma (NAMS) has disclosed Asset Utilization Ratio for 2 consecutive years, with 0.03 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 58.61% to 0.03 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.03 through Dec 2025, down 58.61% year-over-year, with the annual reading at 0.03 for FY2025, 63.37% down from the prior year.
  • Asset Utilization Ratio hit 0.03 in Q4 2025 for NewAmsterdam Pharma, down from 0.04 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.08 in Q2 2025 to a low of 0.02 in Q2 2024.